Key facts
- It has raised $13.0M; the latest was Early Stage VC ($13.0M) in Feb 2026.
- Notable investors include Kinled Holding, Calm/Storm Ventures, BMH Beteiligungs-Managementgesellschaft Hessen, LBBW Venture Capital, Aurum Impact — 13 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 13 names
- ·Watchlist + deal alerts for Oska
- ·The full record, as it builds
Funding rounds
No funding rounds for Oska are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Oska
Developer of a healthcare application designed to support individuals battling chronic kidney disease. The company's application offers an approach to care, treating the whole person, addressing their physical, emotional, and social needs with empathy and understanding, enabling people affected by chronic kidney disease and other chronic conditions to reduce complications and hospital stays and reduce care costs.
- Sector
- Healthcare
- HQ
- Meerbusch, Germany
- Founded
- 2022
- Employees
- 36
- Website
- oska-health.com/
- Ownership
- Privately Held (backing)
Oska doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Oska shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Oska in its N-PORT filings yet. We sweep new filings monthly.